Follow The Filings

FLNA Cassava Sciences Inc.

Health Care, filed as CASSAVA SCIENCES INC (COM), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by FLNA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All FLNA insider trades
  • $749K bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Robert Eugene Anderson Jr. Director
    Buy
    $9,880 19,000 shares at $0.5200 +221% to stake
    Traded Nov 18 Filed Nov 20
  2. Richard Barry CEO
    Buy
    $23K 44,851 shares at $0.5200 +2.3% to stake
    Traded Nov 18 Filed Nov 20
  3. Richard Barry CEO
    Buy
    $64K 132,926 shares at $0.4800 +7.5% to stake
    Traded Nov 17 Filed Nov 19
  4. Richard Barry CEO
    Buy
    $207K 440,206 shares at $0.4700 +33% to stake
    Traded Nov 16 Filed Nov 18
  5. Eric Schoen CFO
    Buy
    $8,400 20,000 shares at $0.4200 +174% to stake
    Traded Nov 16 Filed Nov 18
  6. Robert Christopher Cook COO
    Buy
    $56K 121,575 shares at $0.4600 +886% to stake
    Traded Nov 16 Filed Nov 18
  7. Richard Barry CEO
    Buy
    $278K 306,813 shares at $0.9100 +30% to stake
    Traded Sep 29–30 Filed Oct 1
  8. Richard Barry CEO
    Buy
    $78K 93,091 shares at $0.8400 +9.9% to stake
    Traded Sep 28 Filed Sep 30
  9. Robert Eugene Anderson Jr. Director
    Buy
    $25K 8,600 shares at $2.90 New stake
    Traded Nov 24, 2025 Filed Nov 25, 2025
  10. Richard Barry CEO
    Buy
    $414K 150,000 shares at $2.76 +19% to stake
    Traded Nov 20, 2025 Filed Nov 24, 2025
  11. Richard Barry CEO
    Buy
    $202K 73,385 shares at $2.75 +10% to stake
    Traded Nov 19, 2025 Filed Nov 20, 2025

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 5.02,7.01,9.01
10-Q FORM 10-Q
8-K 2.02,9.01
8-K 8.01
8-K 7.01,8.01,9.01
8-K 3.01
8-K 2.02,9.01
10-Q FORM 10-Q
8-K 5.02,5.07,9.01
8-K 2.02,9.01
10-Q FORM 10-Q
DEF 14A FORM DEF 14A
8-K 5.02
8-K 2.02,9.01
10-K FORM 10-K
8-K 5.03,7.01,9.01
8-K 7.01,8.01,9.01
8-K 1.01
8-K/A 5.02,9.01
8-K 8.01
8-K 5.02,9.01
424B2
8-K 8.01
8-K 2.02,9.01
10-Q FORM 10-Q

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$97.22M -$24.34M -$90.97M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $129.63M $136.53M $97.71M
Total non-current assets * $22.03M $21M $20.65M
Total assets $151.66M $157.53M $118.36M
Total current liabilities $14.2M $11.75M $43.83M
Total non-current liabilities * $0.00 $79,000 $118,000
Total equity $137.47M $145.7M $74.4M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$82.02M -$116.93M -$32.25M
Cash from investing -$414,000 -$103,000 -$581,000
Cash from financing $2.56M $124.47M -$0.239M
Net change in cash * -$79.88M $7.44M -$33.07M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Period archive

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf